⌘K

Home/Filings/4/0001062993-22-012308

4//SEC Filing

Celano Michael 4

Accession 0001062993-22-012308

CIK 0001374690other

View on SEC.gov Company Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 8:28 PM ET

Size

5.5 KB

Accession

0001062993-22-012308

Insider Transaction Report

Form 4

Period: 2022-05-10

Larimar Therapeutics, Inc.LRMR

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-05-10+20,000→ 20,000 total
Exercise: $2.92Exp: 2032-05-10→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The option vests 25% on May 10, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1

filerCIK 0001377582

Filing Metadata

Form type: 4
Filed: May 11, 8:00 PM ET
Accepted: May 12, 8:28 PM ET
Size: 5.5 KB

View on SEC.gov